Simulated Peer Review: See Your NIH Proposal the Way a Study Section Would

Where to Find It

• Per section: Expand any section and click "Simulated Peer Review" to score just that section against the NIH review factor it addresses most, with specific strengths, weaknesses, and revision suggestions. For DP1's Research Strategy Essay specifically, this also runs a structural compliance check (see below).
• Full proposal: Click "Full Proposal Peer Review" above your section list to run a complete review across your entire proposal at once, producing an Overall Impact Score, a mock Summary Statement, and a prioritized Revision Plan.
• Both require an active GrantCopilot account with AI access, including active free trials, and both are available on any supported NIH mechanism.

What You Get Back

• Overall Impact Score: The same 1-9 scale NIH itself uses (1 being Exceptional, 9 being Poor), with the plain-language descriptor NIH assigns to each number.
• Criteria or Factor scores: A breakdown by whichever review model applies to your mechanism, each with a score, a rationale, and specific strengths and weaknesses pulled from your actual text.
• Mock Summary Statement: Written in the voice and structure of a real NIH summary statement, so you know what reviewers would actually write, not just what score they'd give.
• Revision Plan: Priority-ranked revisions ordered by estimated impact on your Overall Impact Score, so you know what to fix first when you don't have time to fix everything.
• Print or save as PDF: Every review, section-level or full-proposal, can be printed or saved for your own records or to share with a mentor or co-investigator.

The Simplified Peer Review Framework, Explained

• Factor 1, Importance of the Research: Combines the old Significance and Innovation criteria into one score (1-9). How important is this work to the field, and do the concepts, methods, or technologies meaningfully increase that importance?
• Factor 2, Rigor and Feasibility: What used to be the Approach criterion, still scored 1-9. Is the science sound, and can it realistically be done well within the proposed timeframe?
• Factor 3, Expertise and Resources: Combines the old Investigator(s) and Environment criteria, but is NOT scored numerically under this framework. Reviewers instead assess it as "appropriate" or flag specific gaps that need explanation.
• The Overall Impact Score still exists and is still scored 1-9, but NIH is explicit that it's a holistic judgment across all three factors, not a mathematical average of them.

Standard Research Grants: R01, R03, R15, R21, R33, R61, U01

• R01, Research Project Grant: The full three-factor assessment with preliminary data expected to directly inform Factor 2. Rigor and Feasibility and Importance of the Research typically carry the most weight.
• R21, Exploratory/Developmental Research Grant: Innovation is weighted heavily under Factor 1, and reviewers are explicitly instructed not to penalize the absence of preliminary data under Factor 2, since R21s exist to fund early-stage ideas within a 6-page Research Strategy and a 2-year, $275,000 budget cap.
• R03, Small Research Grant: Modest innovation is acceptable here; the simulation checks whether the proposed work is genuinely achievable within the mechanism's 2-year, $50,000-per-year constraint rather than penalizing a lack of transformative novelty.
• R15, Academic Research Enhancement Award (AREA): Factor 1 folds in the educational impact on undergraduate trainees alongside scientific importance, and Factor 3 weighs whether the environment supports productive student research training, not just conventional PI productivity.
• R61/R33, Phased Innovation Award: The R61 exploratory phase is judged on whether its milestones are specific, measurable, achievable, relevant, and time-bound (SMART) enough to justify transitioning to R33, with preliminary data explicitly not penalized. The R33 development phase then expects real evidence those R61 milestones were met before scaling up.
• U01, Research Project Cooperative Agreement: The same three factors, plus added weight on your coordination and management plan, milestone structure, and prior experience with NIH cooperative agreements, since U mechanisms involve substantial NIH programmatic involvement that R01s don't.

The NIH Director's Pioneer Award (DP1): A Completely Different Review

• Is this genuinely pioneering, a fundamental new insight or radically different approach, not just a better version of existing work?
• Could success change a broad field, not just advance one narrow line of research?
• Is this a real departure from the investigator's own past and current research, rather than a logical extension of it?
• Is the investigator unusually creative, with concrete evidence, not just credentials or publication count? This is the single most heavily weighted factor in the simulation.
• Is the vision understandable to a non-specialist reviewer? DP1 panels are deliberately chosen for breadth over subfield expertise, so an essay that only lands with an expert in the exact topic is treated as a real weakness.
• Does this actually belong in the Pioneer program? If the same project would work just as well as a standard R01, that undercuts DP1 suitability specifically.
• Structural compliance, checked separately from the scientific critique: the essay must have all seven required elements, Scientific Areas, Project Title, Project Description, Evidence of Innovativeness, How the Research Differs from Past Work, Suitability for the Pioneer Award, and your Effort Commitment statement, each as its own clearly labeled subsection, not just themes woven into the prose. A missing or unlabeled subsection gets flagged even if that content is technically present somewhere else in the essay.

DP1's Extended Review: Competitive Assessment and Interview Readiness

• Overall Competitive Assessment: A holistic read on where your application would likely land against that roughly 4% success rate, calibrated so a merely solid, well-written application without a genuinely field-changing idea does not score in the exceptional range.
• Pioneer Award Fit: Whether the project's uncertainty, flexibility, and potential impact make a standard R01 a poor fit for it specifically.
• Top Competitive Strengths and Gaps: The specific factors most likely to drive (or hurt) your standing against other Pioneer applicants, with each gap flagged by severity.
• Interview Readiness: An assessment of how well the essay would hold up if it advanced to the finalist interview stage.
• Compliance Check: A checklist against DP1's own rules, single PI only, no multiple-PI structure, five-page cap, no preliminary data or detailed budget required, and no resubmissions or renewals permitted for this mechanism.

Career Development and Fellowship Awards

• K01, K08, K23, and general K-series awards: Investigator (the CANDIDATE) and Environment (the mentor team and protected research time, typically 75%+ effort) are the dominant criteria, not the research plan alone. K23 specifically checks that the research involves human subjects or patient-derived materials, since that's a requirement of the mechanism.
• K99/R00, Pathway to Independence: Unlike most fellowships, preliminary data ARE expected here, and the simulation checks whether the K99 research plan is distinct enough from the mentor's own work to demonstrate genuine independent thinking, with the R00 phase plan expected to stand on its own as a fundable independent program.
• F30 (MD/PhD), F31 (predoctoral), and F32 (postdoctoral) fellowships: Investigator (candidate quality) and Environment (sponsor and mentoring track record) are weighted as the two dominant criteria in each case. A transformative research project does not rescue a weak candidate or a mentor with no track record of getting fellows to completion.

SBIR/STTR: Commercial Potential Meets Scientific Merit

• R41/R43, Phase I (STTR/SBIR): Significance covers both scientific significance and commercial or clinical market significance. Approach is judged on technical feasibility with clear go/no-go milestones and a credible path to Phase II. STTR (R41) additionally requires a formal collaboration agreement between the small business and a research institution.
• R42/R44, Phase II (STTR/SBIR): Phase I feasibility is assumed to be established, so the review shifts toward whether the full development plan is achievable, whether regulatory pathways (FDA, where applicable) are addressed, and whether the company's business and commercialization plan is credible.

Non-Research Mechanisms: G07, S10, and U13

• G07, Resources Improvement Grant: A non-research infrastructure grant for improving Internet connectivity and access to digital information resources. The review centers on the baseline problem, the specific planned improvements, measurable outcomes, and a sustainability plan; Innovation and a research-style Investigator track record simply aren't primary factors here.
• S10, Shared Instrumentation Grant: Funds a single piece of shared research equipment. The review checks whether at least three Major Users (each a PD/PI on a distinct, active NIH award) have genuine, substantial need for the instrument, whether the requested specifications match that need, and whether the institution can house and maintain it. There's no research hypothesis to score.
• U13, Conference Cooperative Agreement: Supports a single scientific conference or workshop. The review evaluates the Conference Plan itself, format, agenda, speaker selection, how it compares to related conferences from the past three years, and how NIH program staff involvement is accommodated, since this is a cooperative agreement rather than a standard grant.

Institute-Specific Payline Context

This Is a Simulation, Not a Guarantee

Try It on Your Next NIH Proposal